China Universal Asset Management Co., Ltd. - THERAVANCE BIOPHARMA INC ownership

THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 114 filers reported holding THERAVANCE BIOPHARMA INC in Q1 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.4%.

Quarter-by-quarter ownership
China Universal Asset Management Co., Ltd. ownership history of THERAVANCE BIOPHARMA INC
ValueSharesWeighting
Q3 2023$12
+50.0%
1,357
+79.3%
0.00%
+50.0%
Q2 2023$8
-20.0%
757
-17.1%
0.00%
-33.3%
Q1 2023$10
+25.0%
913
+33.5%
0.00%0.0%
Q4 2022$8
-99.9%
684
-4.5%
0.00%0.0%
Q3 2022$7,0007160.00%
Other shareholders
THERAVANCE BIOPHARMA INC shareholders Q1 2023
NameSharesValueWeighting ↓
Madison Avenue Partners, LP 7,012,226$60,515,5108.59%
Irenic Capital Management LP 2,760,948$23,826,9816.76%
Newtyn Management, LLC 1,841,560$15,892,6633.92%
Weiss Asset Management LP 7,457,060$64,354,4283.81%
Park West Asset Management LLC 1,983,251$17,115,4561.57%
Baupost Group 7,419,226$64,0281.23%
Oasis Management Co Ltd. 953,254$8,226,5820.36%
Chescapmanager LLC 287,333$2,479,6840.32%
GSA CAPITAL PARTNERS LLP 325,985$2,8130.24%
Virtus ETF Advisers LLC 29,232$252,2720.15%
View complete list of THERAVANCE BIOPHARMA INC shareholders